Speed Medical SAE
EEGX:SPMD0.35
EGP
-0.02
(-4.62%)
Speed Medical SAE
EGX:SPMD
(Egyptian Exchange)
Recent
price
0.35
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Speed Medical SAE is an Egypt-based healthcare and medical diagnostics provider engaged in the establishment, operation, and management of clinical laboratory centers, diagnostic imaging facilities, outpatient polyclinics, and specialized healthcare institutions. The company operates through several core business divisions, delivering a comprehensive portfolio of medical services and products that includes clinical pathology, biochemistry, hematology, immunology, microbiology, molecular diagnostics, cytogenetics, and histopathology testing under the Speed Lab brand; advanced diagnostic imaging and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT) scans, 4D ultrasound, digital X-ray, mammography, and echocardiography through the Speed Scan network; outpatient multidisciplinary medical consultations, chronic disease management, and preventive care across internal medicine, cardiology, pediatrics, obstetrics, gynecology, orthopedics, and dermatology under the Speed Clinic banner; inpatient care and day-surgery hospital services; home sample collection, mobile diagnostic units, and corporate occupational health screening programs; and the importation, distribution, and supply of laboratory diagnostic reagents, rapid test kits, and medical consumables to third-party clinical laboratories and healthcare providers. Founded in 2015 and headquartered in Cairo, Egypt, the company caters to individual self-pay patients, corporate employers, private health maintenance organizations (HMOs), medical syndicates, and public healthcare programs across Greater Cairo, the Nile Delta, Upper Egypt, and the Red Sea governorates. In recent developments, Speed Medical SAE has executed comprehensive operational turnaround and network rationalization initiatives to consolidate underperforming branches and optimize capacity utilization; restructured its investment portfolio through strategic asset divestments and the reassessment of non-core ventures, including its participation in Prime Speed Medical Services and standalone hospital development projects; renegotiated and restructured credit facilities with domestic banking partners to optimize debt service and strengthen balance sheet liquidity; broadened its specialized molecular genetics and oncology biomarker testing offerings; and advanced its digital healthcare capabilities through the deployment of centralized laboratory information management systems, automated digital test delivery platforms, and expanded partnership agreements with national insurance networks.